Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06617832

Trial Designs for Evaluating Migraine Treatment

Led by University of Aarhus · Updated on 2026-04-13

128

Participants Needed

2

Research Sites

198 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, advanced balanced placebo design, patients with episodic migraine will receive six treatment conditions in a randomized order.

CONDITIONS

Official Title

Trial Designs for Evaluating Migraine Treatment

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • At least 1-year history of migraine with or without aura based on International Classification of Headache Disorders criteria
  • Episodic migraine with 1 to less than 15 headache days per month featuring migraine symptoms on 2 to 8 days per month for over 3 months
  • Previous or current use of triptans for acute migraine treatment
  • Ability to speak and read Danish
Not Eligible

You will not qualify if you...

  • Chronic migraine or history of chronic migraine in the past 12 months
  • Other primary headache types except infrequent tension-type headache
  • Secondary headache disorders including medication overuse headache
  • Severe psychiatric, vascular, or liver diseases
  • Use of opioids or barbiturates in the month before screening
  • Current use of certain preventive migraine treatments like onabotulinum toxin A or CGRP monoclonal antibodies
  • Contraindications or inability to tolerate triptans
  • Current substance use disorder
  • Implanted metallic or electronic device in the head
  • Presence of cardiac pacemaker or implanted/wearable defibrillator
  • Use of illegal psychotropic drugs less than one week before study; cannabis less than four weeks before study
  • Current or planned pregnancy and lactation as confirmed by tests and contraception guidelines

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Dept. of Psychology and Behavioural Sciences

Aarhus C, Denmark, 8000

Not Yet Recruiting

2

Department of Neurology, Aarhus University Hospital

Aarhus N, Denmark, 8200

Actively Recruiting

Loading map...

Research Team

S

Sigrid Juhl Lunde, MSc, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here